RESEARCHGRADELABTESTED

AP / METABOLIC10MG

01PRODUCT DOSSIER

RETATRUTIDE

METABOLICRESEARCH

Investigational triple GLP-1, GIP and glucagon receptor agonist peptide.

$189.00AUD

AVAILABLE FOR DISPATCH

STRENGTH

QUANTITY

FORMATResearch Compound

DOCUMENTATIONPRODUCT COA

STORAGESTORE AT 2°C–8°C

DISPATCHAUSTRALIA-WIDE

02ABOUT THIS COMPOUND

WHAT IS RETATRUTIDE?

Retatrutide, also known as LY3437943, is an investigational single-molecule triple agonist designed to activate GLP-1, GIP and glucagon receptors. Research examines combined effects on metabolic signalling, glucose regulation, energy expenditure and hepatic lipid pathways.

03RESEARCH APPLICATIONS

Triple-receptor signalling
GLP-1 and GIP pathway research
Glucagon-receptor activity
Energy-expenditure models
Hepatic lipid metabolism

04RESEARCH PROFILE

Distinct triple-receptor profile
Balanced multi-pathway research model
Investigational next-generation peptide
39-amino-acid synthetic design
Multiple strengths available

RESEARCH USE ONLY

NOT FOR HUMAN CONSUMPTION / NOT FOR DIAGNOSTIC OR THERAPEUTIC USE

RESEARCH CODE

LY3437943

PEPTIDE CLASS

Triple GLP-1 / GIP / glucagon receptor agonist

MOLECULAR WEIGHT

Approximately 4,731 Da

CHAIN LENGTH

39 amino acids

FORMAT

Lyophilised powder

PURITY

≥ 98%

AVAILABLE

10MG / 20MG / 30MG / 40MG

RELATED COMPOUNDS

VIEW ALL PRODUCTS →